Managing musculoskeletal infections in children in the era of increasing bacterial resistance

JAAPA : Official Journal of the American Academy of Physician Assistants
David R Godley

Abstract

The continually changing spectrum of bacterial resistance in children with musculoskeletal infections underscores the importance of prompt diagnosis coupled with timely and appropriate treatment. This article focuses on two serious childhood musculoskeletal infections commonly encountered by primary care providers: acute hematogenous osteomyelitis and septic arthritis.

References

Feb 18, 2003·JAMA : the Journal of the American Medical Association·Melinda M NeuhauserJohn P Quinn
Apr 24, 2004·Journal of Pediatric Orthopedics·Uri GivonAbraham Ganel
Aug 5, 2004·The Journal of Bone and Joint Surgery. American Volume·Mininder S KocherJames R Kasser
Sep 27, 2006·Journal of Pediatric Orthopedics. Part B·Mohamed Medhat Zamzam
Jun 27, 2008·Journal of Pediatric Orthopedics·Jesús Saavedra-LozanoOctavio Ramilo
Sep 2, 2009·The Journal of Bone and Joint Surgery. British Volume·S-N KangM Ramachandran
Jan 30, 2010·Expert Review of Anti-infective Therapy·Nada S Harik, Mark S Smeltzer
Jun 23, 2010·Seminars in Plastic Surgery·Jason H CalhounMark Shirtliff
Apr 5, 2011·Orthopaedics & Traumatology, Surgery & Research : OTSR·P JourneauP Lascombes
Jul 3, 2013·The Medical Clinics of North America·Paul S Pottinger
Oct 3, 2013·The Journal of the American Academy of Orthopaedic Surgeons·Julie Balch Samora, Kevin Klingele
Jan 24, 2014·The New England Journal of Medicine·Heikki Peltola, Markus Pääkkönen

❮ Previous
Next ❯

Citations

Jun 4, 2016·International Journal of Molecular Sciences·Luca CastellazziSusanna Esposito
Jun 1, 2018·Journal of Pediatric Orthopedics. Part B·Antonio AndreacchioFederico Canavese
May 5, 2018·Journal of Pediatric Orthopedics·Rachel D QuickSarmistha B Hauger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.